E N D
1. Ascending thoracic aneurysm repair with CPB and circulatory arrest
(case presentation)
Darko J. Vodopich MD
Antonio Cooper MD
MetroHealth Medical Center - CWRU
Department of Anesthesiology
2. History CC: 81 y.o. white male coming to ED after found in the bathroom. + LOC, no amnesia. Responsive on arrival.
C/o stroke like symptoms:
headache,
confusion,
left sided weakness,
unable to turn the head to the left side
3. History cont.: Allergy: Ciprofloxacin, Levaquin
PMHx:
HTN well controlled on Lisinopril and HCTZ
Type 2 DM well controlled by diet/exercise
Prostate cancer (on Megestrol)
Occasional CP (no AMI in the past)
COPD
PVD
4. History cont.: PSHx:
Inguinal hernia repair
Umbilical hernia repair
Past Anesthesia Hx:
GA
No complications with GA
5. Physical: HEENT: PEERL, EOMI
MP class 1, TMD 5 cm, Mouth opening 4 FB, good neck mobility, own dentition in a good shape
Cor: RRR, S1S2, no murmurs, no thrill, tones silent, distant on auscultation
Pulmo: decreased sounds bilaterally, no crackles or wheezing
Extremities: no gross abnormalities, left sided weakness
Neurological: AOx3, left sided focal signs
ASA 5, Case type: Emergency
6. Laboratory and studies report: CBC: WBC=8.4, Hb=11, Hct=35, Plt=207
Na=128, K=3.6, HCO3-=19, Cl=98, BUN=11, Creat=0.6, Glu=131
Pt=12.0, PTINR=1.02, PTT=42.9
ECG: NSR~100 BPM, nonspecific S-T changes, no signs of acute ischaemia
ECHO: 19 July 2002: EF 74%, no ischaemic changes
Adenosine myocardial perfusion test: 19 July 2002: NSR, left axis anterior hemiblock, mild S-T changes. No evidence of ischaemia. Normal test.
7. Ultrasound done in Oberlin hospital:
8. Ultrasound done in Oberlin hospital:
9. Chronology: Pt taken to OR 15.
Difficulty cross matching the blood
Anesthesia start time @ 20:28 with a-line and 2 large bore 16 G i.v. lines in place
Smooth i.v. induction: Fentanyl 100+150+200+250 mcg;
Midazolam 5mg, Vecuronium 10 mg.
Easy ventilation and intubation; ET 8, Grade 1 view, atraumatic, secured @ 23 cm.
Left IJ 9 F introducer placed, PAC introduced, good waves and wedge detected, secured @ 54 cm. Patient tolerated procedure well. No complications.
Initial CI=2.4, SVO2=75%, CVP=14, PAP=24/14 mmHg
10. Intraoperative facts: Maintenance of anesthesia before bypass:
Isoflurane 1.0%, O2 = 2L, Air = 2L.
Fentanyl: 0.05 mcg/kg/min
Vecuronium: 3mg/h
Other drips:
Amicar
Sodium nitroprusside
NTG
Neosynephrine
BIS: ~ mid 40s
BP titrated to a mean of 80s
ABG @ the beginning surgery: pH=7.43, CO2=31.8, O2=207, HCO3=21.1, BE=-2.0, HCT=30, Na=123, K=3.4, Glu=160
11. Intraoperative during bypass: 1st time 2nd time 3rd time
On pump 22:12 00:05 02:40
Off pump 22:56 01:48 04:05
Circulatory arrest @ 22:35 = BIS 00
Temperature during arrest: 18 C
MAP 15-20s during circulatory arrest
ABG on the pump: pH=7.40, CO2=35, O2=336, HCO3=22, BE=-2.1, HCT=22, Na=123, K=3.8, Glu=167
12. Intraoperative events:
13. Intraoperative events (2):
14. Intraoperative facts: Total surgery time 20:28-05:02= 514 min
Total bypass time: 44min+103min +85 min= 232 min
Total circulatory arrest time = 27 minutes
EBL ~ 2000 ml
PRBCs= 6 units
Platelets = 6 packs
Fluids: 2200 ml
Urinary output = 120 ml (hemolyzed)
Blood clot removed from right atrium
Patient expired 05:30 AM
CAA identified in the blood
15. Cold agglutinins antibody (CAA)
16. Cold agglutinins antibody - CAA: Common but usually unimportant - in serum of almost all healthy patients
AHA caused WAB = 1:85.000; caused CAA = 1:300,000
Female/male = 1.5/1.0
Associated with:
Infectious mononucleosis (60%)
Lymphoreticular neoplasms
Mycoplasma pnuemoniae
IgM autoantibodies against RBC I-antigen
17. Cold agglutinins antibody - CAA: Thermal amplitude - blood temperature below CAA react
Higher thermal amplitude = more malignant CAA (35 Co)
Routine screen by blood banks for CAA @ 37Co
Significance of CAA is determined by:
Agglutination of RBC in 20 Co saline
Agglutination of RBC in 30 Co albumin
If tests are negative significant hemolysis is unlikely (Leach AB, Van Hasselt GL, Edwards JC:Cold agglutinins and deep hypothermia. Anesthesia 38:140;1983)
18. CAA - physical exam and distribution: PE: may reveal
nothing unusual
pallor only, unless the patient is observed during or shortly after cold exposure.
purplish discoloration of the ears, forehead, tip of the nose, and digits may then be observed.
Distribution is provided by a study of 78 patients with persistent cold agglutinins:
31 lymphoma (40%),
24 chronic, idiopathic CAD (31%)
13 Waldenstrm syndrome (16%)
6 chronic lymphocytic leukemia (CLL) (8%) (Crisp, 1982)
19. CAA - Ddx: DDX:
Cryoglobulinemia
Warm AIHA (Warm antibodymediated autoimmune hemolytic anemia )
Neoplasms
Drug-induced immune hemolytic anemia
Heparin-induced thrombocytopenia/thrombosis syndrome (HITTS)
Drug-induced hemolytic anemia
Infections
20. Management of CAA and CPB:. Depends on : 1.titers, 2.thermal amplitude
1) During the bypass RBC agglutination can be determined by mixing the blood with cold cardioplegia
2) Dilute the blood sample to simulate the dilution with CPB and cool it down. (may not have the reaction)
Many institutions avoid hypothermic CPB if CAA present
Cold cardioplegia may produce agglutination in small heart blood vessels
If hypothermia required despite CAA
preoperative plasmapheresis to reduce titers
limit hypothermia to temperature exceeding thermal amplitude
use standard hemodilution techniques
21. Cold cardioplegia with normothermic bypass and no plasmapheresis
normothermic CPB
cardioplegia 37 Co to washout CAA
4 C cold cardioplegia
Malignant cold CAA
Consider total washout technique - exchange patients blood with donors blood
Heat all anesthetic gases, IV Fluids, blood, and plasma
Keep room warm
Use washed RBCs Management of CAA and CPB:.
22. Thanks for the attention